Search Back New search Go to resultsDiseaseMain groupHematologic NeoplasmsProtocol groupAggressive LymphomasHodgkin LymphomaIndolent LymphomasDiseaseHodgkin LymphomaMantle Cell LymphomaNHL, B-Cell Type, Diffuse Large CellNHL, B-Cell Type, Follicular Grade I-IIIaNHL, B-Cell Type, Follicular grade IIIbNHL, T-cell typeNHL, T-Cell Type, Other Specified Leukemias, Aggressive NK-Cell LeukemiaNHL, T-Cell Type, Peripheral, UnspecifiedSubgroupICD10C81.-C82.-C82.7C82.9C83.1C83.3C84.4C84.5C94.7-MeSHLymphoma, Large B-Cell, DiffuseLymphoma, Mantle-CellLymphoma, Non-HodgkinLymphoma, T-Cell, PeripheralSequenceChemotherapyChemo-substanceCarboplatinCisplatinCytarabineDexamethasoneGemcitabinePeg asparaginaseChemo-substanceCarboplatinCisplatinCytarabineDexamethasoneGemcitabinePeg asparaginaseChemo-substanceCarboplatinCisplatinCytarabineDexamethasoneGemcitabinePeg asparaginaseChemo-substanceCarboplatinCisplatinCytarabineDexamethasoneGemcitabinePeg asparaginaseNo. Substances34 RadiotherapySupportive therapySupportive substanceBalanced Crystalloid SolutionCotrimoxazoleDexamethasoneDimetindenFamotidineFosaprepitantGranisetronMagnesium sulfateParacetamolPegfilgrastimPotassium chlorideSupportive substanceBalanced Crystalloid SolutionCotrimoxazoleDexamethasoneDimetindenFamotidineFosaprepitantGranisetronMagnesium sulfateParacetamolPegfilgrastimPotassium chlorideSupportive substanceBalanced Crystalloid SolutionCotrimoxazoleDexamethasoneDimetindenFamotidineFosaprepitantGranisetronMagnesium sulfateParacetamolPegfilgrastimPotassium chlorideSupportive substanceBalanced Crystalloid SolutionCotrimoxazoleDexamethasoneDimetindenFamotidineFosaprepitantGranisetronMagnesium sulfateParacetamolPegfilgrastimPotassium chlorideNo. Substances511Protocol classificationTherapy classificationalternativecurrent standardIntensityStandard doseTherapy indicationFirst lineseveral possibleTherapy phaseInductionTherapy intentioncurativeRisksAnemia Hb below 8g/dlEmetogenicity (MASCC/ESMO)Febrile NeutropeniaGastrointestinal ToxicityHyperbilirubinemiaIncrease AminotransferasesLeukopeniaNeuropathyNeutropeniaSepsisThrombocytopenia below 50 000/µl only studiesPublicationAuthorLi XTessoulin BDiseaseExtranodales NK/T-Zell Lymphom, Stadium III-IV, ErstlinieNon-Hodgkin-Lymphom / Hodgkin LymphomOriginDepartment of Oncology, The First Affiliated Hospital of Zhengzhou UniversityNantes Medical University, Nantes, FranceProtocols in Revision 2 protocols foundProtocols under revision.DDGP (Cisplatin 20 / Gemcitabine 800 / PEG-Asparaginase 2500 / Dexamethasone (7.5/15)), extranodal NK/T-cell Lymphoma (PID2349 V1.0)DHAC - Carboplatin 5 / Cytarabine 2000 / Dexamethasone 40, Non-Hodgkin Lymphoma / Hodgkin Lymphoma. (PID2346 V1.0)
